Search

Your search keyword '"Yamamoto, Kei"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Yamamoto, Kei" Remove constraint Author: "Yamamoto, Kei" Publisher elsevier b.v. Remove constraint Publisher: elsevier b.v.
118 results on '"Yamamoto, Kei"'

Search Results

5. Relapse of toxocariasis after completion of four-week treatment with albendazole.

6. Impact of controlled blood pressure and pulse rate at discharge on clinical outcomes in patients with ST-segment elevation myocardial infarction.

7. Autopsy of tetanus with foot gangrene as portal of entry.

8. Clinicopathological evaluation of oral leukoplakia: a single-center study of 676 cases in Japan.

9. Presence and Relevance of Myocardial Bridge in LAD-PCI of CTO and Non-CTO Lesions.

10. Characteristics of preventive intervention acceptance for international travel among clients aged 60 years and older from a Japanese multicenter pretravel consultation registry.

12. Influence of daily temperature on the occurrence of ST-elevation myocardial infarction.

13. Impact of Eruptive vs Noneruptive Calcified Nodule Morphology on Acute and Long-Term Outcomes After Stenting.

14. Potential usage of anterior nasal sampling in clinical practice with three rapid antigen tests for SARS-CoV-2.

15. Impact of rotational atherectomy on the incidence of side branch compromise in calcified bifurcation lesions undergoing elective percutaneous coronary intervention.

16. Impact of Nonobstructive Left Main Coronary Artery Atherosclerosis on Long-Term Mortality.

17. Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital

19. Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19.

20. Complications related to veno-arterial extracorporeal membrane oxygenation in patients with acute myocardial infarction: VA-ECMO complications in AMI.

21. Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients.

24. Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission.

27. Determinants of Greater Peak radiation skin dose in percutaneous coronary intervention for chronic total occlusion.

28. Association of slow flow with clinical factors in intravascular ultrasound-guided percutaneous coronary intervention for patients with left main trunk-acute myocardial infarction.

29. Rabies post-exposure prophylactic vaccination for returning travelers to Japan.

31. Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result?

32. Intentional switch between 1.5-mm and 1.25-mm burrs along with switch between rotawire floppy and extra-support for an uncrossable calcified coronary lesion.

33. Conservative management of severe coronary artery hematoma and dissection following stent implantation.

35. A unique mechanism of restenosis after drug-coated balloon in peripheral artery: Insight from optical frequency domain imaging.

37. Clinical outcomes after acute myocardial infarction according to a novel stratification system linked to a rehabilitation program.

38. Intravascular ultrasound enhances the safety of rotational atherectomy.

41. Comparison of mid-term clinical outcomes between “complete full-metal jacket strategy” versus “incomplete full-metal jacket strategy” for diffuse right coronary artery stenosis with drug-eluting stents.

44. Comparison of the epidemiology and microbiology of peripheral line– and central line–associated bloodstream infections.

45. Use of polymerase chain reaction in the diagnosis of Whipple's disease.

46. Major adverse cardiac and bleeding events associated with non-cardiac surgery in coronary artery disease patients with or without prior percutaneous coronary intervention.

48. Secreted phospholipase A2 modifies extracellular vesicles and accelerates B cell lymphoma.

49. Hair Follicular Expression and Function of Group X Secreted Phospholipase A2 in Mouse Skin.

50. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas

Catalog

Books, media, physical & digital resources